Want to join the conversation?
$BLL 2Q15 Call: Results were in line with our expectations and the operations are fundamentally strong. Headwinds represented approx. $0.23 per diluted share in 2Q15 and $0.39 YTD. On Feb. 19 we announced a proposed offer for Rexam, earlier this week Ball shareholders voted overwhelmingly for the share issuance proposal.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.